Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates

Código QR

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates

Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction of fracture risk. The objective of this stu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gu T, Eisenberg Lawrence DF, Stephenson JJ, Yu J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Osteoporosis diphosphonates physician's practice patterns cross-sectional studies patient compliance Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/309fb60186fe45d7a56b54deb089379a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Diagnosis and management of osteoporosis in the older senior
por: Sheryl F Vondracek, et al.
Publicado: (2009)

Physicians′ perception about electronic medical record system in Makkah Region, Saudi Arabia
por: Hani Abdulsattar Shaker, et al.
Publicado: (2015)

Transient osteoporosis of the hip: Physicians the occupation of at risk
por: Abolfazl Fattah, et al.
Publicado: (2021)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Richard Derman, et al.
Publicado: (2009)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Oliver Bock, et al.
Publicado: (2008)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: John Sunyecz
Publicado: (2008)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
por: Nagy EE, et al.
Publicado: (2020)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives
por: Lin X, et al.
Publicado: (2015)

Whose advocacy counts in shaping elderly patients’ satisfaction with physicians’ care and communication?
por: Kahana B, et al.
Publicado: (2018)

Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan B, et al.
Publicado: (2015)

A review of minodronic acid hydrate for the treatment of osteoporosis
por: Tanishima S, et al.
Publicado: (2013)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009)

Osteonecrosis asociada al uso de bifosfonatos: A propósito de un caso clínico
por: Anguita C,Timoleón, et al.
Publicado: (2006)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Silvia Migliaccio, et al.
Publicado: (2007)

Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Eldecalcitol for the treatment of osteoporosis
por: Noguchi Y, et al.
Publicado: (2013)

Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
por: Chin KY, et al.
Publicado: (2014)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population
por: Xu J, et al.
Publicado: (2013)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

Fracture liaison services: improving outcomes for patients with osteoporosis
por: Walters S, et al.
Publicado: (2017)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan T, et al.
Publicado: (2013)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
por: Victor G Vogel
Publicado: (2008)

Olive oil in the prevention and treatment of osteoporosis after artificial menopause
por: Liu HL, et al.
Publicado: (2014)

Sarcopenic obesity and cognitive performance
por: Tolea MI, et al.
Publicado: (2018)

lncRNA GAS5 Is Upregulated in Osteoporosis and Downregulates miR-21 to Promote Apoptosis of Osteoclasts
por: Cong C, et al.
Publicado: (2020)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014)